Research
-
ResMed touts CPAP survival benefits for sleep apnea after HHS doubts therapy efficacy
The ResMed-funded analysis of a French database comes on the heels of a government review finding the evidence does not back a link between continuous positive airway pressure therapy and clinically important outcomes.
By Greg Slabodkin • Sept. 09, 2021 -
iStock
Hospital telehealth leveling off at one-fifth of medical appointments, research finds
And of the facilities reporting higher virtual volumes, many said they expected telehealth use to decline over the long term, according to the survey from KLAS Research and the Center for Connected Medicine.
By Rebecca Pifer • Sept. 08, 2021 -
Master Sgt. Hecht, Matt. (2020). [Photograph]. Retrieved from Flickr.
Pandemic spurs rise of other infections contracted at healthcare facilities
The largest increase at hospitals from 2019 to 2020 was seen in bloodstream infections associated with central line catheters, according to the CDC.
By Hailey Mensik • Sept. 02, 2021 -
Christopher Furlong via Getty Images
Smoking pot before knee, hip replacements linked with more complications
With marijuana use rising quickly in U.S. adults aged 45 to 64 years, three studies presented at the American Academy of Orthopaedic Surgeons meeting sought to find out if consumption affects outcomes.
By Nick Paul Taylor • Sept. 02, 2021 -
Courtesy of Abbott
Abbott predicted to quickly take share from Boston Scientific's Watchman: survey
The poll of 56 electrophysiologists by SVB Leerink analysts is somewhat more encouraging for Boston Scientific than an earlier survey, but still highlights the threat to the franchise as it loses its monopoly in the space.
By Nick Paul Taylor • Aug. 26, 2021 -
Fotolia
Patients were still hesitant to seek medical care out of virus fears this spring, survey finds
Despite reopenings, one in 10 nonelderly adults put off needed medical care this spring, an April survey from the Urban Institute found.
By Hailey Mensik • Aug. 19, 2021 -
Fotolia
Outpatient revenue drives hospital volume rebound in June, Kaufman Hall says
The report's year-to-date trends in outpatient visit growth add to color from medtech companies reporting electives rebounding in recent financial results.
By Hailey Mensik • Aug. 04, 2021 -
Mayo Clinic named U.S. News top hospital for sixth straight year
The list, which already examines specialty areas like knee replacements, added seven new measures including care for spinal fusion and hip fracture.
By Shannon Muchmore • July 28, 2021 -
Adobe Stock
PerkinElmer inks $5.3B takeover of antibody provider BioLegend
Flush with revenue from COVID-19 testing, the medtech is betting the company can sustain a high growth rate amid competition from BD and Thermo Fisher.
By Nick Paul Taylor • July 27, 2021 -
Adeline Kon/Healthcare Dive/MedTech Dive
Deep DiveMedtech pay to doctors plunged in 2020 as COVID-19 pummeled electives, in-person services fell
Zimmer Biomet had the biggest drop, cutting general payments nearly 80% to $63 million. Other notable decreases include Stryker, J&J's DePuy Synthes and Boston Scientific.
By Ricky Zipp • July 12, 2021 -
Permission granted by The Boldt. Co.
U.S. News hospital rankings to add back surgery, hip fracture and overuse
The publication will rank seven new procedures and conditions, as well as a new category "because a pattern of overuse or low-value care is not compatible with being a high-quality provider."
By Hailey Mensik • June 30, 2021 -
Adeline Kon/MedTech Dive
Black patients were more likely to die of COVID-19 largely due to inferior hospitals
A recent study in JAMA Network Open showed how inequities in housing influence where Black people seek care and how that affects the quality of care they receive.
By Samantha Liss • June 21, 2021 -
National Cancer Institute, NIH
In first, FDA approves KRAS-blocking cancer drug from Amgen
After decades of scientists unsuccessfully targeting the KRAS gene, Lumakras is the first drug proven effective. The FDA Friday also approved companion diagnostics from Qiagen and Guardant Health.
By Ned Pagliarulo • UPDATED: May 29, 2021 at 12:35 p.m. -
Courtesy of Boston Scientific
Boston Scientific's Watchman shows low stroke rate in large registry at ACC
The fast-growing product performed well in an analysis of more than 36,000 people presented at the American College of Cardiology meeting, with low adverse event rates that surprised even the study's author.
By Susan Kelly • May 17, 2021 -
Sarah Silbiger via Getty Images
Paclitaxel, uncoated stents for PAD show similar mortality in real world study
The review of outcomes for Medicare beneficiaries contrasts a 2018 meta-analysis that identified a mortality signal for patients treated with drug-coated stents and balloons. Still, JAMA editors said mortality rates are troublingly high.
By Susan Kelly • May 17, 2021 -
Courtesy of Boston Scientific
TAVR readmission rates vary widely between hospitals for unknown reasons: study
Length of stay and discharge disposition only explained 15% of the inter-hospital variation. The study's authors have called for efforts to identify practices associated with low rates or readmission.
By Nick Paul Taylor • May 10, 2021 -
EU MDR delay has not made new rules easier to stomach: exec poll
Most of the 115 respondents to the Climedo Health survey said resources and lack of clarity were top challenges, with about a third indicating compliance efforts will cost their company 5% to 10% of annual revenue.
By Ricky Zipp • April 15, 2021 -
Adobe Stock
Fewer heart tests ordered for telehealth patients in pandemic
Research published in JAMA Network Open also found those using the virtual services were more likely to be Asian, Black or Hispanic.
By Susan Kelly • April 06, 2021 -
Medtechs top pharma in cash to doctors for consulting, travel: Health Affairs study
The majority of sector payments, also covering royalties, speaking fees and food, came from the likes of Medtronic, J&J, Zimmer, Stryker and Abbott. Specialties targeted included neurosurgery, orthopaedics and cardiology.
By Ricky Zipp • April 06, 2021 -
Alex Wong via Getty Images
Hospitals flailed amid COVID-19 crisis, are unsure of future, OIG says
Executives said they were worried about their workers experiencing trauma and concerned a shrinking recruitment pool for nurses could exacerbate staffing shortages.
By Ron Shinkman • March 25, 2021 -
AstraZeneca, Oxford vaccine prevents COVID-19 in big US study amid controversy overseas
A two-shot regimen was 79% effective at protecting people from COVID-19, which should support the fourth clearance of a vaccine in the U.S. and calm safety concerns abroad.
By Ben Fidler • March 22, 2021 -
Insulin pump adoption seen climbing 21% in 2021 on wearables boom: survey
The SVB Leerink poll of 101 endocrinologists and nurse practitioners also projects a shift in market position among top players like Medtronic, Insulet and Tandem Diabetes Care.
By Ricky Zipp • March 05, 2021 -
Moderna
FDA panel endorses Moderna's coronavirus vaccine
A group of independent experts supported use of the biotech's shot, which is likely to receive an emergency authorization from the agency within days.
By Ned Pagliarulo • UPDATED: Dec. 17, 2020 at 6:02 p.m. -
Getty Images
Docs paid by ICD makers more likely to favor manufacturer: JAMA study
Yale researchers found patients were more likely to receive certain cardiac devices from the company that made the largest payment to their doctor, though quality of care did not appear to be affected.
By Susan Kelly • Nov. 04, 2020 -
Adobe Stock
Duke researchers pitch CDS tool to keep electives going during COVID-19 surges
JAMA Network Open authors found that using predictive modeling to develop a clinical decision support tool could help determine patient length of stay and use of a ventilator in procedures like knee and hip replacements.
By Ron Shinkman • Nov. 02, 2020
